Table 1: Demographic profile of patients with non-severe and severe COVID-19.
Total |
Non-severe |
Severe |
P-value |
|
N = 1368 |
n = 845 |
n = 523 |
||
Age in yearsa |
45 ( ± 16.82) |
40.29 ± 14.94 |
56.86 ± 14.49 |
< 0.001 |
Sex |
||||
Female |
669 |
533 (50.4%) |
136 (43.7%) |
0.015 |
Male |
699 |
523 (49.5%) |
176 (56.59%) |
0.018 |
Comorbidities |
|
|
|
|
Diabetes |
259 |
79 (9.3%) |
180 (34.41%) |
< 0.001 |
Hypertension |
393 |
114 (13.49%) |
279 (53.34%) |
< 0.001 |
Cardiovascular Disease |
171 |
38 (4.5%) |
133 (25.43%) |
< 0.001 |
Chronic Lung Disease |
142 |
58 (6.9%) |
84 (16.1%) |
< 0.001 |
Chronic Kidney Disease |
165 |
42 (5%) |
123 (23.51%) |
< 0.001 |
Liver Disease |
21 |
8 (0.9%) |
13 (2.48%) |
0.024 |
HIV |
8 |
4 (0.4%) |
4 (0.7%) |
0.492 |
Leukemia |
3 |
0 (0%) |
3 (0.5%) |
0.028 |
Cancer |
40 |
15 (1.7%) |
25 (4.7%) |
0.001 |
aNon-normal distribution; variables are reported in Mean ± Standard Deviation for a large population (Central Limit Theorem), instead of Median with 25th and 75th interquartile ranges.